Tomivosertib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Tomivosertib, covering 2023-03-22 to 2025-10-21. Get the full timeline:
Most recent: Clinical Trial Update: Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1]